ADAM9 and esophageal squamous cell carcinoma: It is worth noting that after high-level expression of miR-126, it can inhibit DNMT1, thereby affecting the expression level of ADAM9 through the pathway, and then regulating the related physiological functions of esophageal squamous cell carcinoma.